These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10435395)

  • 1. The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET.
    Meyer JH; Cho R; Kennedy S; Kapur S
    Psychopharmacology (Berl); 1999 Jun; 144(3):279-81. PubMed ID: 10435395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study.
    Meyer JH; Kapur S; Eisfeld B; Brown GM; Houle S; DaSilva J; Wilson AA; Rafi-Tari S; Mayberg HS; Kennedy SH
    Am J Psychiatry; 2001 Jan; 158(1):78-85. PubMed ID: 11136637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone.
    Waldinger MD; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 2001 Jun; 21(3):293-7. PubMed ID: 11386492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients.
    Trichard C; Paillère-Martinot ML; Attar-Levy D; Recassens C; Monnet F; Martinot JL
    Am J Psychiatry; 1998 Apr; 155(4):505-8. PubMed ID: 9545996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors.
    Massou JM; Trichard C; Attar-Levy D; Feline A; Corruble E; Beaufils B; Martinot JL
    Psychopharmacology (Berl); 1997 Sep; 133(1):99-101. PubMed ID: 9335087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study.
    Zanardi R; Artigas F; Moresco R; Colombo C; Messa C; Gobbo C; Smeraldi E; Fazio F
    J Clin Psychopharmacol; 2001 Feb; 21(1):53-8. PubMed ID: 11199948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between central and peripheral serotonin 5-HT2A receptors: a positron emission tomography study in healthy individuals.
    Cho R; Kapur S; Du L; Hrdina P
    Neurosci Lett; 1999 Feb; 261(3):139-42. PubMed ID: 10081968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open pilot study of nefazodone in depression with anger attacks: relationship between clinical response and receptor binding.
    Mischoulon D; Dougherty DD; Bottonari KA; Gresham RL; Sonawalla SB; Fischman AJ; Fava M
    Psychiatry Res; 2002 Dec; 116(3):151-61. PubMed ID: 12477599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophrenia.
    Verhoeff NP; Meyer JH; Kecojevic A; Hussey D; Lewis R; Tauscher J; Zipursky RB; Kapur S
    Psychiatry Res; 2000 Oct; 99(3):123-35. PubMed ID: 11068194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory.
    van Laar MW; Volkerts ER; Verbaten MN; Trooster S; van Megen HJ; Kenemans JL
    Psychopharmacology (Berl); 2002 Aug; 162(4):351-63. PubMed ID: 12172688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of paroxetine and nefazodone on 5-HT1A receptor sensitivity.
    Sargent P; Williamson DJ; Pearson G; Odontiadis J; Cowen PJ
    Psychopharmacology (Berl); 1997 Aug; 132(3):296-302. PubMed ID: 9292630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability of a simple non-invasive method for the evaluation of 5-HT2 receptors using [18F]-setoperone PET imaging.
    Kapur S; Jones C; DaSilva J; Wilson A; Houle S
    Nucl Med Commun; 1997 May; 18(5):395-9. PubMed ID: 9194079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial.
    Sharpley AL; Williamson DJ; Attenburrow ME; Pearson G; Sargent P; Cowen PJ
    Psychopharmacology (Berl); 1996 Jul; 126(1):50-4. PubMed ID: 8853216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine.
    Attar-Lévy D; Martinot JL; Blin J; Dao-Castellana MH; Crouzel C; Mazoyer B; Poirier MF; Bourdel MC; Aymard N; Syrota A; Féline A
    Biol Psychiatry; 1999 Jan; 45(2):180-6. PubMed ID: 9951565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET.
    Trichard C; Paillère-Martinot ML; Attar-Levy D; Blin J; Feline A; Martinot JL
    Schizophr Res; 1998 May; 31(1):13-7. PubMed ID: 9633832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperone.
    Ngan ET; Yatham LN; Ruth TJ; Liddle PF
    Am J Psychiatry; 2000 Jun; 157(6):1016-8. PubMed ID: 10831488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone.
    Yatham LN; Liddle PF; Dennie J; Shiah IS; Adam MJ; Lane CJ; Lam RW; Ruth TJ
    Arch Gen Psychiatry; 1999 Aug; 56(8):705-11. PubMed ID: 10435604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.
    Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC
    J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug.
    Taylor DP; Carter RB; Eison AS; Mullins UL; Smith HL; Torrente JR; Wright RN; Yocca FD
    J Clin Psychiatry; 1995; 56 Suppl 6():3-11. PubMed ID: 7649970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.